Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PHGDH | O43175 | 18/20 | 0.87 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | XBP1 | P17861 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.50 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20063236 | 0.93 | PHGDH (1.00) | PHGDHLMNAKMT2AMEN1POLB | |
| SCHEMBL20063203 | 0.73 | PHGDH (1.00) | PHGDHLMNAKMT2AMEN1POLB | |
| SCHEMBL7519980 | 0.72 | PHGDH (0.65) | PHGDH | |
| SCHEMBL20063226 | 0.72 | PHGDH (1.00) | PHGDHLMNAKMT2AMEN1POLB | |
| SCHEMBL20063235 | 0.71 | PHGDH (0.85) | PHGDHLMNAKMT2AMEN1POLB | |
| SCHEMBL20063264 | 0.71 | PHGDH (0.58) | PHGDHLMNAKMT2AMEN1POLB | |
| Bromide SCHEMBL7525103 | 0.71 | PHGDH (0.64) | PHGDH | |
| SCHEMBL20063224 | 0.70 | PHGDH (1.00) | PHGDHLMNAKMT2AMEN1POLB | |
| SCHEMBL20063223 | 0.69 | PHGDH (1.00) | PHGDHLMNAKMT2AMEN1POLB | |
| SCHEMBL20063202 | 0.69 | PHGDH (1.00) | PHGDHLMNAKMT2AMEN1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180105508-A1 | INHIBITORS OF PHOSPHOGLYCERATE DEHYDROGENASE (PHGDH) AND USES THEREOF | WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) | 2018-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180105508-A1 | INHIBITORS OF PHOSPHOGLYCERATE DEHYDROGENASE (PHGDH) AND USES THEREOF | PHGDH, PGD, PGK1 | PHGDH 1/4885LMNA 3829/4885KMT2A 3904/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.